1346689-83-5

Usage

Uses

Used in Pharmaceutical Research:
1-(4-bromophenyl)cyclopentanemethanol is used as a key compound in pharmaceutical research for its potential therapeutic applications. It is valued for its ability to modulate the activity of certain receptors in the body, which makes it a promising candidate for the development of new drugs.
Used in Organic Synthesis:
In the field of organic synthesis, 1-(4-bromophenyl)cyclopentanemethanol serves as an important intermediate. Its unique structure allows for further chemical reactions to create a variety of complex organic molecules, contributing to the advancement of chemical research and the creation of novel compounds.
Used in Treatment of Inflammatory Conditions:
1-(4-bromophenyl)cyclopentanemethanol is used as a therapeutic agent for inflammatory conditions due to its potential to alleviate symptoms associated with inflammation.
Used in Pain Management:
1-(4-bromophenyl)cyclopentanemethanol is also being studied for its use in pain management, potentially offering a new avenue for the treatment of chronic and acute pain.
Used in Neurodegenerative Disorder Treatment:
1-(4-bromophenyl)cyclopentanemethanol is being investigated for its role in treating neurodegenerative disorders, with the aim of developing new therapeutic strategies to combat conditions such as Alzheimer's, Parkinson's, and other related diseases.

Upstream product

• 1267113-92-7 1-(4-bromophenyl)cyclopentane-1-carbaldehyde 
• 143328-19-2 1-(4-bromophenyl)cyclopentane-1-carbonitrile 
• 16532-79-9 4-Bromophenylacetonitrile 
• 143328-24-9 1-(4-bromophenyl)cyclopentanecarboxylic acid 
• 285-67-6 Cyclopentene oxide 
• 18620-02-5 (4-bromophenyl)magnesium bromide 

Downstream Products

• 1616924-20-9 methanesulfonic acid 1-(4-bromophenyl)cyclopentylmethyl ester 
• 1616924-21-0 2-[1-(4-bromophenyl)cyclopentyl]acetonitrile 
• 1616924-22-1 2-[1-(4-bromophenyl)cyclopentyl]acetamidine hydrochloride 
• 1616924-23-2 5-benzyloxy-2-[1-(4-bromophenyl)cyclopentylmethyl]-6-hydroxypyrimidine-4-carboxylic acid tert-butyl ester 
• 1616924-24-3 5-benzyloxy-2-[[1-(4-bromophenyl)cyclopentyl]methyl]-6-hydroxypyrimidine-4-carboxylic acid 
• 1616924-25-4 5-benzyloxy-2-[1-(4-bromophenyl)cyclopentylmethyl]-6-hydroxypyrimidine-4-carboxylic acid [2-(tert-butyldimethylsilanyloxy)ethyl]isopropylamide 
• 1616924-26-5 5-benzyloxy-2-[1-(4-bromophenyl)cyclopentylmethyl]-6-hydroxypyrimidine-4-carboxylic acid (2-hydroxyethyl)isopropylamide 
• 1616924-27-6 9-benzyloxy-6-[1-(4-bromophenyl)cyclopentylmethyl]-2-isopropyl-3,4-dihydro-2H-pyrazino[1,2-c]pyrimidine-1,8-dione 
• 1616922-09-8 4-[1-(9-hydroxy-2-isopropyl-1,8-dioxo-1,3,4,8-tetrahydro-2H-pyrazino[1,2-c]pyrimidin-6-ylmethyl)cyclopentyl]benzonitrile 
• 344463-64-5 (1R_.2S)-trans-propane-2-sulfonic acid [2-(4-bromo-phenyl)-cyclopentyl]-amide 

Relevant academic research and scientific papers

PYRIMIDONE DERIVATIVES AND THEIR USE IN THE TREATMENT, AMELIORATION OR PREVENTION OF A VIRAL DISEASE

The present invention relates to a compound having the general formula (I), optionally in the form of a pharmaceutically acceptable salt, solvate, polymorph, codrug, cocrystal, prodrug, tautomer, racemate, enantiomer, or diastereomer or mixture thereof, which are useful in treating, ameloriating or preventing a viral disease. Furthermore, specific combination therapies are disclosed.

QUINOLINONE DERIVATIVES

The present invention relates to compounds of the formula (I), salts thereof, to pharmaceutical compositions containing them and their use in medicine. In particular, the invention relates to compounds as activators of AMPK.

Cyclopentyl sulfonamide derivatives

The present invention provides certain cyclopentyl sulfonamide derivatives of formula (I): useful for potentiating glutamate receptor function in a mammal. It also relates to novel cyclopentyl sulfonamide derivatives, to processes for their preparation and to pharmaceutical compositions containing them.